Improved tissue perfusion during pressure regulated hyperthermic regional isolated perfusion. A clinical study
暂无分享,去创建一个
C. Wildevuur | H. Koops | J. Oldhoff | P. Mook | W. Fontijne
[1] C. Wildevuur,et al. Isolated hindlimb perfusion in dogs: the effect of perfusion pressures on the oxygen supply (ptO2 histogram) to the skeletal muscle. , 1985, Surgery.
[2] J. Oosterhuis,et al. Improved tissue perfusion during pressure‐regulated hyperthermic regional isolated perfusion in dogs , 1984, Journal of surgical oncology.
[3] W. J. van Dijk,et al. High‐flow isolation perfusion of the rat hind limb in vivo , 1982, Journal of surgical oncology.
[4] E. V. van Slooten,et al. Dosimetry in isolation perfusion of the limbs by assessment of perfused tissue volume and grading of toxic tissue reactions. , 1982, European journal of cancer & clinical oncology.
[5] H. Koops,et al. Hyperthermic regional perfusion with melphalan and a combination of melphalan and actinomycin D in the treatment of locally metastasized malignant melanomas of the extremities , 1982, Journal of surgical oncology.
[6] L. Firestone,et al. Transcutaneous oxygen and carbon dioxide monitoring. Use in adult surgical patients in an intensive care unit. , 1981, Archives of surgery.
[7] H. Bicher,et al. Circulatory responses of malignant tumors during hyperthermia. , 1981, Microvascular research.
[8] K. Tremper,et al. Effects of hypoxia and shock on transcutaneous Po2 values in dogs , 1979, Critical care medicine.
[9] C. Song,et al. Effect of hyperthermia on vascular functions of normal tissues and experimental tumors; brief communication. , 1978, Journal of the National Cancer Institute.
[10] E. van der Ploeg,et al. Some aspects of the treatment of primary malignant melanoma of the extremities by isolated regional perfusion , 1977, Cancer.
[11] E. Sugarbaker,et al. Survival and regional disease control after isolation‐perfusion for invasive stage I melanoma of the extremities , 1976, Cancer.
[12] T. Hallböök,et al. Skin and muscle blood flow during regional perfusion with hyperthermal perfusate. , 1974, Scandinavian Journal of Thoracic and Cardiovascular Surgery.
[13] H. S. Koops. Melanoblastoma malignum cutis van de extremiteiten regionale perfusie en recidief , 1973 .
[14] F. Golomb. Perfusion of Melanoma , 1972 .
[15] K. Messmer,et al. Acute Normovolemic Hemodilution , 1972 .
[16] C. McBride. Advanced Melanoma of the Extremities: Treatment by Isolation-Perfusion With a Triple Drug Combination , 1970 .
[17] C. Heidelberger,et al. Selective heat sensitivity of cancer cells. Biochemical and clinical studies , 1967 .
[18] O. Creech,et al. Techniques of regional perfusion. , 1966, Surgery.
[19] A. Gilman,et al. The initial clinical trial of nitrogen mustard. , 1963, American journal of surgery.
[20] J. Stehlin,et al. Perfusion for malignant melanoma of the extremities. , 1963, American journal of surgery.
[21] E. Krementz,et al. Current status of regional chemotherapy perfusion. , 1963, American journal of surgery.
[22] K. Reemtsma. Complications of regional cancer chemotherapy by perfusion and infusion technics. , 1963, American Journal of Surgery.
[23] W. Dewey,et al. Continuous monitoring of leakage during regional perfusion. , 1961, Archives of surgery.
[24] E. Krementz,et al. The effect of increased oxygen tension on the tumoricidal effect of nitrogen mustard. , 1961, Surgery.
[25] R. F. Ryan,et al. Chemotherapy of Cancer: Regional Perfusion Utilizing an Extracorporeal Circuit , 1958, Annals of surgery.